Day 2: Thursday March 23, 2017

Moderators: Pankaj Qasba (NHLBI)

Donna Lochner (FDA)

Speakers:

• 1:40 - 2:00 pm: Bridget Wilson - scientist
• 2:00 - 2:20 pm: Marvin Slepian - clinician
• 2:20 - 2:40 pm: Victor Oancea - industry R&D Technology Director
• 2:40 - 3:00 pm: panel discussion

The objectives of this session are to provide perspectives from stakeholders - Scientist, Clinicians, Industry leaders - on how multiscale modeling has changed their own research, practice and commercialization efforts over the last decade; and how they view the acceptance level of end users for more widespread use of models in their fields. 

Each of the three speakers in this session will have 15-minutes for presentations, with a 15-minute Q&A panel at end.

The specific charge to the speakers is to:

• present their background and how they came to use and embrace modeling for their own work;
• comment on how modeling has provided insight for their work, not otherwise provided by other means;
• discuss how their field has changed over the last decade in regard to the use and acceptance as computational models as part of standard practice;
• provide some ideas on how modeling could be further used in the future in their field.

Comments/Questions (please identify yourself):

Back to MAIN AGENDA